EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 19 October 2023

Europe’s health resilience relies on its ability to innovate

Read EFPIA's new op-ed on POLITICO.eu

In the face of continued global geopolitical uncertainty, Europe is paying increasing attention to its sovereignty, security and resilience.

The availability of critical medicines and vaccines is central to Europe’s health preparedness. As governments across Europe rebuild and learn from the pandemic, the policies that can build health resilience and strengthen health systems are in sharp focus; the concept of open strategic autonomy is top of the EU policy agenda.

To close the gap, EFPIA proposes to...

The medicine investment gap between US and EU has increased by 1000% over the past 20 years.

The EU Pharmaceutical Legislation will shape the future of research, development and manufacturing in Europe for decades to come. Unless changes are made, Europe will become reliant on other regions' medical innovation and our citizens will wait longer for the latest advances in care.

Have a look at our new webpage on the EU Pharmaceutical Legislation.

News

EFPIA Japan Day 2023
15 October 2023

With a delegation from EFPIA in Brussels, EFPIA Japan recently held “EFPIA Day” in Tokyo Read more

Events

POLITICO Health Care Summit
24 October 2023 (Brussels and online)

From pandemic to permacrisis? Europe’s next health care challenge Read more

High-Level Conference on the Value and Role of Incentives in Life Science
07 November 2023 (Brussels, Belgium)

Under the auspices of the Ministry of Health of the Czech Republic Read more

Do Novel Oncology Combination Therapies Have a Place Within the EU Legislative Framework?
14 November 2023 (Bella Center Copenhagen, Denmark)

The Impact of Challenges for Novel Combination Therapies on Equality of Access Between European Patients Read more

Awareness session for SMEs on the reform of the EU pharmaceutical legislation
24 November 2023 (Online)

Register by 15 November 2023 Read more

What we are reading

Which diabetes specific patient reported outcomes should be measured in routine care?
On 18 October 2023 (ScienceDirect)

A systematic review to inform a core outcome set for adults with Type 1 and 2 diabetes mellitus: The European Health... Read more

Swedish stakeholders ask for revisions of EU’s pharma reform
On 17 October 2023 (Euractiv)

The Swedish Association of the Pharmaceutical Industry, LIF, representing 90 private companies, calls for major improvements... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu